Jan Garfinkle founded Arboretum Ventures in 2002 with over 19 years of senior management experience in life science startups, including Advanced Cardiovascular Systems (ACS) and Devices for Vascular Intervention (DVI), both of which were acquired by Eli Lilly and then became the foundation of Guidant Corporation. She joined each company early in their development, and held key management roles in marketing, clinical research and sales at these companies.

Prior to founding Arboretum Ventures, Jan was President of Strategic Marketing Consultants. SMC provided extensive market analysis, regulatory and reimbursement review, business plan development and due diligence to life science start ups, venture funds, and universities. She holds a BS in Bioengineering from the University of California at Berkeley and an MBA from the Wharton School of the University of Pennsylvania. Currently, she serves on the boards of MichBio, the University of Michigan National Technology Transfer Advisory Board, and the Michigan Venture Capital Association.